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~ L-Arglnlne Restores Normal Endothelium-Medlated 
Relaxat ion in Hyparcholestemlemlo Rabbits 
Exposed to Tobacco Smoke 
Stuart J. Hutchisen, Michael Ibarra, Tony M. Chou, Richard E. Stevers, 
Kanu Chatterjee, Stanton A, Glantz, Prakash C. Dsedwania, William 
W. Parminy. University of California, San Francisco, CA 
Hypercholastorolemia (HG) and tobacco smoke are associated with impaired 
endothalium-mediatnd relaxatian. L-Arginine (L-Arg) has been 5hewn to pro- 
tect against endothelial dysfunction secondary to HC, We sought to invastJ- 
gate whether L-Arg would protect against endothelial dysfunction secondary 
to environmental tobacco smoke.exposure (ETS) in an animal model of 
atherosclerosis. Aodie dngs of male New Zealand white rabbits wore studied 
in organ baths and isometric tension recorded. Rings were preconVacted 
with norepinephdn to ECS0, then exposed to acetylcholine [10 -9 to 10 -4 M]. 
32 rabbits were rendered HC by diet; half were randomized to L-Arg (10 
weeks of 2.25% in ddnking water) and half to ETS for 10 weeks in a 2 x 2 
design. HC ral~its received ETS and L-Arg (SA group, n = 8), received ETS 
and no L-Arg (SC group, n = 8), received no ETS and L-Arg (CA greup, n = 
8), and received no ETS and no L-Arg (CC group, n = 8). 8 normal non-HC 
rabbits served as controls. Maximal relaxation of SC, SA, CC, CA (-46 ~: 8, 
-78:1: 5, -70 • 3, -75 :l: 3) was less (p < 0.05) than of normals (-93:1: 3; 
P < 0.05). Maximal relaxation of SC was less than SA (p < 0.05), and CC 
was less than CA (p < 0.05). 
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ETS exposure results in significantly impaired endothelium-mediated relax- 
ation, L-Arg restores nom~al endothelium-mediated vaserelaxation in ETS/HC 
and HC rabbits, 
11:00 
Vitamin E Restores Impaired Acetylcholine- 
Mediated Vasodllatation Secondary to 
Environmental Tobacco Smoke 
Tony M. ChoU, Stuart J. Hutc~ison, Sevedn P. Schwarzacher, 
Kdshnankutty Sudhir, Prakash C. Deedwani¢ William W. Pamdey. 
University of California, San Francisco, CA 
Envimnmantal tobacco smoke (ETS) impairs endolhelium-dependant va- 
sedilation in vitro. This study inveatJgatud alfecls of ETS on acetylCholine 
(Ach)-mediated blood pressure (BP) changes in vivo. 17 New Zealand white 
rabbits were fed a cho~'~.terel diet (0,3%) for 10 weeks (Chol). 7 animals 
sewed as diet o0n~rols (nonETS) and 10 (ETS) were exposed to ETS for C 
houre/day. In adddion, 4 nenETS and 3 ETS animals received vitamin E for 
B weeks prior and dunng their Chol-diet (V'd and nonVit). 5 rabbits senmd as 
healthy controls (nonChol). BP was measured before and after 3 rain wP.h 
incremental IV doses of rmrepinep~dne (NE, 1, 4, 20 p.g/kg), Ach (3.3, 10, 
30 p.g/kg) and niboglycedne (NTG, 1, 10, 40/~,'kg), Results: Following NE, 
the nonChol had a higher BP mspoase compared to Chol (+74.3 • 5% vs 
+58.9 ± 4%, p = 0.04). Max BP response tO Ach was attenuated in Ch01 
oore~ to controls (-79,5 • 1.6% vs -44,3 4- 7.3%; p = 0.0002) and in 
ETS vs nonETS (-65 • 4,5% vs -29.8 :~ 9.P/o; p = 0.005). Ach max BP re- 
sponse was improved in the V'~ co n~..,amd to no n'~rlt ( - -~0,0  :~ 9.3% vS -33,3 
9.3%; p = 0.06). NTG caused greater BP change in nonChol oompared 
to Chol (-70.0 :t: 7.7% V:; -33.8 4- 3.8%; p + 0.01) with a trend towards 
greater change in nonETS vs ETS (-41.2 :E 2,5% vs 2"7.4 :t: 5.9%; p = 0.07). 
Conclusions: IBofh ETS and hyperchofeeterolemia independently impair Ach 
and WIG*mediated BP responses. V'damtn E appasm to attenuate this ETs 
effect and papally restores response tO AC~. The antioxidant effect of vitamin 
E may be protective against ~ damage from tobacco smoke. 
11:15 
~ Impartance of Ischemia for Myocardial 
Angiogenesls: Effect of Basic Rbroblast Growth 
Factor on Well Developed Collaterals 
Matie Shou, Venugopai Thirumurd, Sharmtni Rajanayagarn, Daisy 
F. I~ArOUS, Everal~ Hedge, Stephen E, El0stein, Ellis R Unger. Care~logy 
Branch, NHLBI, e ~  MD 
Basic fibtoblast growth fac~ (bFGF), an angioganic growth favor, is cup 
rently b'le asbject eta Phase I tdal in ets with ischemic heart o'Lsease. The 
etficacy of bFGF is well established in animal models of myoCan~ ischemla; 
however, the in~ortanse Of my0cen:llal ~ as a pdmer for coronary an- 
giaganasts is unknown. This study was das~ned to evaluate the potential of 
bFGF to enhance coronary collateral pedusien in the absence of myocardial 
ischemla. A seeond~ goal was to ascertain whether the eCects of ~ef  
bFGF trealment would be detectable in the vmy long term (6 months). Thirty 
dogs were ~ubjected to amerokHnduced occlusion of the left circumflex 
COronary artenJ and randomized/wk~e to Veatment: 10 and 183 days po~t 
ameroid placement, bFGF (1.74 mg/d x 7 d) or vehicle wen) injected via 
the left atrium, a regimen proven eflic~tOUS in previous sludies. Collateral 
pedusion was evaluated uring maximal vassd~a~on as the ischernic~normal 
zone ratio (IZ/I¢~ pdor to the Second b-eatmant and again 19 days later. 
pay IO.-I~ mNZ(,~y,1~) ,, ~ylS~-1~ BJNZ (day L'0~) 
bFGF 0.51 4- 0.0,~ bFGF 0.50 4, 0.02 
0.51 4, 0.03 vehicle 0.57 4, 0.04 
Vehicle 0.48 :J: 0.01 bFGF 0.49 + 0.01 
0.48 4. 0.01 vel'dde 0.47 4:0.02 
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